
Results
2
2 companies
Newron Pharmaceuticals
Market Cap: CHF 420.3m
A biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States.
NWRN
CHF 21.00
7D
4.7%
1Y
95.9%
Cosmo Pharmaceuticals
Market Cap: CHF 1.9b
Focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide.
COPN
CHF 117.00
7D
-0.5%
1Y
75.9%